Literature DB >> 21543417

Renal inflammation and elevated blood pressure in a mouse model of reduced {beta}-ENaC.

Heather A Drummond1, Samira C Grifoni, Ahmed Abu-Zaid, Monette Gousset, Rumbidayzi Chiposi, John M Barnard, Beau Murphey, David E Stec.   

Abstract

Previous studies suggest β-epithelial Na(+) channel protein (β-ENaC) may mediate myogenic constriction, a mechanism of blood flow autoregulation. A recent study demonstrated that mice with reduced levels of β-ENaC (β-ENaC m/m) have delayed correction of whole kidney blood flow responses, suggesting defective myogenic autoregulatory capacity. Reduced renal autoregulatory capacity is linked to renal inflammation, injury, and hypertension. However, it is unknown whether β-ENaC m/m mice have any complications associated with reductions in autoregulatory capacity such as renal inflammation, injury, or hypertension. To determine whether the previously observed altered autoregulatory control was associated with indicators of renal injury, we evaluated β-ENaC m/m mice for signs of renal inflammation and tissue remodeling using marker expression. We found that inflammatory and remodeling markers, such as IL-1β, IL-6, TNF-α, collagen III and transforming growth factor-β, were significantly upregulated in β-ENaC m/m mice. To determine whether renal changes were associated with changes in long-term control of blood pressure, we used radiotelemetry and found that 5-day mean arterial blood pressure (MAP) was significantly elevated in β-ENaC m/m (120 ± 3 vs. 105 ± 2 mmHg, P = 0.016). Our findings suggest loss of β-ENaC is associated with early signs of renal injury and increased MAP.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21543417      PMCID: PMC3154591          DOI: 10.1152/ajprenal.00694.2010

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  36 in total

1.  Functional and structural correlates of glomerulosclerosis after renal mass reduction in the rat.

Authors:  Karen A Griffin; Maria M Picken; Monique Churchill; Paul Churchill; Anil K Bidani
Journal:  J Am Soc Nephrol       Date:  2000-03       Impact factor: 10.121

2.  Altered whole kidney blood flow autoregulation in a mouse model of reduced beta-ENaC.

Authors:  Samira C Grifoni; Rumbidzayi Chiposi; Susan E McKey; Michael J Ryan; Heather A Drummond
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-04

3.  Long-term telemetric measurement of cardiovascular parameters in awake mice: a physiological genomics tool.

Authors:  G M Butz; R L Davisson
Journal:  Physiol Genomics       Date:  2001-03-08       Impact factor: 3.107

Review 4.  Impaired renal autoregulation: implications for the genesis of hypertension and hypertension-induced renal injury.

Authors:  B F Palmer
Journal:  Am J Med Sci       Date:  2001-06       Impact factor: 2.378

Review 5.  Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms.

Authors:  Rodger Loutzenhiser; Karen Griffin; Geoffrey Williamson; Anil Bidani
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-05       Impact factor: 3.619

6.  TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats.

Authors:  Ahmed A Elmarakby; Jeffrey E Quigley; John D Imig; Jennifer S Pollock; David M Pollock
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-11-07       Impact factor: 3.619

Review 7.  Aldosterone: a risk factor for vascular disease.

Authors:  Mario Fritsch Neves; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

8.  Renal myogenic response: kinetic attributes and physiological role.

Authors:  Rodger Loutzenhiser; Anil Bidani; Lisa Chilton
Journal:  Circ Res       Date:  2002-06-28       Impact factor: 17.367

Review 9.  Aldosterone and end-organ damage.

Authors:  Annis M Marney; Nancy J Brown
Journal:  Clin Sci (Lond)       Date:  2007-09       Impact factor: 6.124

10.  Pressure-induced constriction is inhibited in a mouse model of reduced betaENaC.

Authors:  Lauren G VanLandingham; Kimberly P Gannon; Heather A Drummond
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-06-24       Impact factor: 3.619

View more
  15 in total

Review 1.  ENaCs and ASICs as therapeutic targets.

Authors:  Yawar J Qadri; Arun K Rooj; Catherine M Fuller
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-25       Impact factor: 4.249

Review 2.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

3.  βENaC acts as a mechanosensor in renal vascular smooth muscle cells that contributes to renal myogenic blood flow regulation, protection from renal injury and hypertension.

Authors:  Heather A Drummond; David E Stec
Journal:  J Nephrol Res       Date:  2015-06-26

Review 4.  Blood pressure and amiloride-sensitive sodium channels in vascular and renal cells.

Authors:  David G Warnock; Kristina Kusche-Vihrog; Antoine Tarjus; Shaohu Sheng; Hans Oberleithner; Thomas R Kleyman; Frederic Jaisser
Journal:  Nat Rev Nephrol       Date:  2014-01-14       Impact factor: 28.314

5.  Altered myogenic vasoconstriction and regulation of whole kidney blood flow in the ASIC2 knockout mouse.

Authors:  Kimberly P Gannon; Susan E McKey; David E Stec; Heather A Drummond
Journal:  Am J Physiol Renal Physiol       Date:  2014-12-17

6.  Impaired myogenic constriction of the renal afferent arteriole in a mouse model of reduced βENaC expression.

Authors:  Ying Ge; Kimberly Gannon; Monette Gousset; Ruishing Liu; Beau Murphey; Heather A Drummond
Journal:  Am J Physiol Renal Physiol       Date:  2012-03-14

Review 7.  Purinoceptors, renal microvascular function and hypertension.

Authors:  Z Guan; M N Makled; E W Inscho
Journal:  Physiol Res       Date:  2020-04-17       Impact factor: 1.881

8.  βENaC and ASIC2 associate in VSMCs to mediate pressure-induced constriction in the renal afferent arteriole.

Authors:  Yan Lu; David E Stec; Ruisheng Liu; Michael Ryan; Heather A Drummond
Journal:  Am J Physiol Renal Physiol       Date:  2022-03-14

Review 9.  Renal microvascular dysfunction, hypertension and CKD progression.

Authors:  Anil K Bidani; Aaron J Polichnowski; Rodger Loutzenhiser; Karen A Griffin
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-01       Impact factor: 2.894

10.  βENaC is a molecular component of a VSMC mechanotransducer that contributes to renal blood flow regulation, protection from renal injury, and hypertension.

Authors:  Heather A Drummond
Journal:  Front Physiol       Date:  2012-08-28       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.